Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine

BACKGROUND: The development of resistance to cytotoxic chemotherapy continues to be a major obstacle for successful anticancer therapy. It has been shown that cells exposed to toxic concentrations of commonly used cancer chemotherapy agents develop DNA hypermetylation. Hence, demethylating agents co...

Descripción completa

Detalles Bibliográficos
Autores principales: Segura-Pacheco, Blanca, Perez-Cardenas, Enrique, Taja-Chayeb, Lucia, Chavez-Blanco, Alma, Revilla-Vazquez, Alma, Benitez-Bribiesca, Luis, Duenas-González, Alfonso
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563479/
https://www.ncbi.nlm.nih.gov/pubmed/16893460
http://dx.doi.org/10.1186/1479-5876-4-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563479/
https://www.ncbi.nlm.nih.gov/pubmed/16893460
http://dx.doi.org/10.1186/1479-5876-4-32

Ejemplares similares